# Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

> **NCT02992015** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 2 (actual)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma

## Interventions

- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT02992015
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-23
- **Primary completion:** 2018-02-28
- **Final completion:** 2024-03-06
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992015, "Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02992015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*